The historical rank and industry rank for Moderna's Intrinsic Value: Projected FCF or its related term are showing as below: MRNA's Price-to-Projected-FCF is not ranked * in the Biotechnology industry. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions. Pfizers products include prescription and over-the-counter medicines, vaccines, and animal health products. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. MRNA has negative Net Debt. You can manage your stock email alerts here. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Please enter Portfolio Name for new portfolio. Compared to the current market price of 128.52 USD, The higher the solvency score, the more solvent the company is. Investors use this metric to determine how a company's stock price stacks up to its intrinsic value. Price return decomposition is a method of analyzing the factors that contribute to the changes in the market capitalization of a company. MRNA has positive Free Cash Flow for the last twelve months. This feature is only available for Premium Members, please sign up for. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. MRNA has very high three-year average ROIC (Return on Invested Capital): 38%. The Price to Book ratio or P/B is calculated as market capitalization divided by its book value. We take the average of these two methods to estimate the intrinsic value as accurately as possible. Moderna Inc's solvency score is Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)? It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Sie knnen Ihre Einstellungen jederzeit ndern, indem Sie auf unseren Websites und Apps auf den Link Datenschutz- und Cookie-Einstellungen oder Datenschutz-Dashboard klicken. GuruFocus has detected 1 Severe Warning Sign with MRNA. The historical rank and industry rank for Moderna's Intrinsic Value: Projected FCF or its related term are showing as below: The historical data trend for Moderna's Intrinsic Value: Projected FCF can be seen below: * For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. For the Biotechnology subindustry, Moderna's Intrinsic Value: Projected FCF, along with its competitors' market caps and Intrinsic Value: Projected FCF data, can be viewed below: * Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. The agreement between Moderna and Harbour BioMed is significant because it could lead to the development of new and innovative treatments for cancer. Past performance is a poor indicator of future performance. Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. Nucleic acid-based immunotherapies are a promising area of research, and the agreement between these two companies will help to accelerate the development of these treatments. >, open = false, 5000)" 80% was chosen as a happy median after taking the above ideas into consideration. Moderna has created a technology platform that may bring personalized medicine to patients one day. The company is very efficient at using invested capital to generate operating income. As of today (2023-05-15), Moderna's intrinsic value calculated from the Discounted Earnings model is $144.45. Warning! href="https://www.alphaspread.com/security/nasdaq/mrna/discount-rate" MRNA's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -71% to 29%. Because of this, the intrinsic value is not an absolute number, but rather a range. VI App is operated under 8BIT Global Pte Ltd. is Moderna Intrinsic Value - Moderna ($NASDAQ:MRNA) is a biotechnology company that specializes in creating mRNA-based medicines and vaccines. Intrinsic Value v/s Book Value v/s Market Price over Time 62/100. class="item active" Kerjaya Prospek dividend calculator KERJAYA PROSPEK Group Bhd Announces 0.02 Cash Dividend, COF Stock Fair Value Capital One Financial Acquires Velocity Mobile to Enhance Digital Customer Experience, Vicor Corporation Stock Intrinsic Value Vicor Corporations Modular Power Architecture Set to Expand, Investec Group Intrinsic Value Calculator Investec Group Encourages Staff to Work Four-Day Week in the Office, Crown Holdings Stock Fair Value First Trust Advisors LP Trims 38.3% of Stake in Crown Holdings, Inc, Citigroup Cuts Ties with Science Applications International Co. through Share Sale, Intermediate Capital dividend calculator Intermediate Capital Group PLC Declares 0.522 Cash Dividend, NVDA Stock Set to Soar Higher as Q2 Guidance Surpasses Record Highs. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Moderna Inc insiders have only sold shares Moderna Inc's profitability score is Past performance is a poor indicator of future performance. [ Read More ]. 98/100. Investors use this metric to determine how a company's stock price stacks up to its intrinsic value. The cash flow of the future is discounted to its current value at the discount rate. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. Wall Street analysts forecast MRNA stock price to rise over the next 12 months. Overvalued by 23%. Moderna has expertise in mRNA technology, while Harbour BioMed has expertise in immunotherapy. Therefore, Moderna's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0. All currency related amount are indicated in the company's associated stock exchange currency. However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. MRNA's ROE (Return on Equity) has significantly increased in the last 3 years from -33% to 27%. An increase in revenue indicates that the company is generating more sales, while an improvement in net margin indicates that the company is becoming more efficient and generating more profit from each dollar of sales. These symbols will be available throughout the site during your session. href="https://www.alphaspread.com/security/nasdaq/mrna/summary" MRNA has positive Operating Income for the last twelve months. (President), who In-depth view into Moderna Inc (NASDAQ:MRNA) intrinsic valuation including the DCF Valuation, Relative Valuation, its profitability and solvency analysis, and more. is 223.18 USD The reason we are doing this is we found that historically stock prices are more correlated with earnings than free cash flow. Zacks Style Scores Education - Learn more about the Zacks Style Scores. worth of shares. This means that the company has more cash and short-term investments (9B USD) than debt (831M USD). and have not bought any shares, The intrinsic value of one Thank you for viewing the detailed overview of Moderna's Intrinsic Value: Projected FCF provided by GuruFocus.com. Open Relative Valuation. Margin of Safety (FCF Based) using Discounted Cash Flow model for Moderna is Moderna is also developing preclinical programs in a variety of disease areas, including cardiovascular, central nervous system, and infectious diseases. MRNA stock discount rate: cost of equity and WACC. [ Read More ]. Overvalued by 23%. Click here to check it out. What is the Intrinsic Value of one MRNA stock? GuruFocus has detected 1 Severe Warning Sign with MRNA. 2004-2023 GuruFocus.com, LLC. Out of 51 bloggers that have blogged about Moderna, 76% of them are bullish, while the sector average is approximately 69% are bullish on the biotechnology sector in the last three months. MRNA has been removed from your Stock Email Alerts list. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Compared to the current market price of 128.52 USD, TipRanks->. Intrinsic Value (%) is Intrinsic Value Previous Close, expressed as a percentage. Fundamental company data provided by Morningstar, updated daily. the intrinsic value of nature.3 Defenders of intrinsic value, while in agreement over the importance of ascribing intrinsic value to nature, nevertheless, disagree among themselves over what such ascriptions mean. class="item" The latest price of the firm is $133.77. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Co-Founder, Independent Non Exec. MRNA stock valuation using Discount Cash Flow valuation method. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. 2023, Nasdaq, Inc. All Rights Reserved. This feature is only available for Premium Members, please sign up for. :class="open && 'disabled'" The details of how we calculate the intrinsic value of stocks are described in detail here. As of today (2023-06-02), Moderna's Intrinsic Value: Projected FCF is $0.00. Moderna Inc is a biotechnology company that develops and manufactures drugs, vaccines, and diagnostics. Disclaimer:The information contained in this article represents the views and opinion of the writer only, and not the views or opinion of TipRanks or its affiliates Read full disclaimer >. $129.53 It has also reported $17.00 in earnings per share for the first nine months of 2021, missing analyst estimates of $17.36 for that period. May 30, 2023 Capturing life-changing. I am excited to see where the company and the stock price go from where it is today. Discover stocks tailored to your investment strategy. MRNA has positive Free Cash Flow for the last twelve months. Type a symbol or company name. December 17, 2021 at 6:15 PM CEO of Moderna Inc ( 30-Year Financial, Insider Trades) Stephane Bancel ( insider trades) sold 19,000 shares of MRNA on 12/16/2021 at an average price of $278.47 a. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. The company focuses on the development of messenger RNA therapeutics and vaccines. Learn more about Zacks Equity Research reports. Discover stocks tailored to your investment strategy. Therefore, Moderna's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0. Compared to the current market price of 128.52 USD, Overvalued by 23%. The first stage is called the growth stage; the second is called the terminal stage. sold 560M USD 98.41 A typical discount rate can be anywhere between 6% - 20%. Create your Watchlist to save your favorite quotes on Nasdaq.com. All Rights Reserved. If the company's predictability rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database. According to Wall Street analysts, the average 1-year price target for class="item" Please click on the following links to see related term pages. MRNA intrinsic value, competitors valuation, and company profile. However, GuruFocus DCF calculator is actually a Discounted Earnings calculator, the EPS without NRI is used as the default. MRNA's Revenue has dropped by 33% over the past 12 months. 62/100. Income Statement, Balance Sheet, Cash Flow Statement. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. This includes personalizing content and advertising. All Rights Reserved. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. In November 2020, I estimated that its Covid-19 vaccine now branded SpikeVax -- could add as much as $35 billion to Moderna's revenues. class="item" The historical rank and industry rank for Moderna's Intrinsic Value: Projected FCF or its related term are showing as below: MRNA's Price-to-Projected-FCF is not ranked * in the Biotechnology industry. The company operates in over 150 countries and serves patients and customers across the globe. MRNA stock valuation using valuation multiples. Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not. Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Analysis of the financial position and solvency of the company. Novavax is a clinical-stage biotechnology company focused on the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Turning to Wall Street, Moderna has a Hold consensus rating, based on six Buys, six Holds, and three Sells assigned in the past three months. You can manage your stock email alerts here. www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under the terms of the agreement, Moderna will have an exclusive sub-licensable license to exploit a panel of sequences against multiple targets derived from Harbours proprietary heavy chain only antibody discovery platform. To calculate the intrinsic value of a stock, we use two valuation methods: DCF Valuation and Relative Valuation. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. When I calculated the stocks intrinsic value by modeling discounted cash flows, I pegged it at $497.53. MRNA has positive Net Income for the last twelve months. The grey bar indicates the Intrinsic Value: Projected FCF's extreme value range as defined by GuruFocus. Moderna stock (NASDAQ: MRNA) has declined by almost 40% thus far in 2022 and currently trades at about $142 per share. As of today (2023-06-02), Moderna's intrinsic value calculated from the Discounted Cash Flow model is $18.32. Stock quotes provided by InterActive Data. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The firm develops technologies that enable the development of mRNA medicines for diverse applications. >, open = false, 5000)" class="item" The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses. 2004-2023 GuruFocus.com, LLC. href="https://www.alphaspread.com/security/nasdaq/mrna/financials/income-statement" The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The company is headquartered in Cambridge, Massachusetts and currently employs 2,700 full-time employees. During the last Only PremiumPlus Member can access this feature. But the future is not predetermined. 98.41 The change in earnings, on the other hand, represents the actual changes in the company's earnings over the given period. After listening to Stephen Hoge, the president of Moderna, speak at the Piper Sandler virtual healthcare conference, I am confident that the sky is the limit for this company. The DCF Value (33.04 USD) of MRNA stock is 74% less than its price (128.52 USD). Past performance is a poor indicator of future performance. href="https://www.alphaspread.com/security/nasdaq/mrna/solvency" Fiscal Year: 2022-12-31 Splits [From:To]: None Currency: USD Moderna Inc (MRNA-RM.ME) clears Graham's qualitative criteria for the NCAV (Net-Net) investment grade. Insider trading data is out there for all who want to use it. Moderna's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as. MRNA's Price-to-Projected-FCF is not ranked, 200 Technology Square, Cambridge, MA, USA, 02139. Gurus may be added or dropped from the GuruFocus site at any time. Gurus may be added or dropped from the GuruFocus site at any time. open = false, 5000)" with a low forecast of 93.93 USD and a high forecast of 451.5 USD. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. If it is less than 5%, we use 5% instead. MRNA's short-term assets (12B USD) exceed its short-term liabilties (3B USD). Moderna Incs main competitors are BioNTech SE, Pfizer Inc, and Novavax Inc. BioNTech SE is a German biotechnology company founded in 2008. The companys strong fundamentals and long-term potential make it a great buy at its current price. Knowing the full range of possible stock intrinsic values gives a complete picture of the investment risks and opportunities. Overvalued by 23%. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. As of today (2023-05-17), Moderna's intrinsic value calculated from the Discounted Cash Flow model is $18.32. class="item" 98/100. The Companys mRNA medicines are designed to direct the bodys cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. MRNA has positive Net Income for the last twelve months. Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. At the same time, Moderna now has $8.9 billion sitting in the bank that can be reinvested back into its pipeline and quickly bring other mRNA vaccines/drugs to market. I am very bullish on this stock at its current price. The price return decomposition breaks down the market cap return into two main components: the change in the price-to-earnings (P/E) multiple and the change in company earnings (as well as the change in revenue and net margin). A stock's price/fair value is simply its current market price divided by the fair value estimate. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. :class="open && 'disabled'" The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Weightings from 0% to 100% to more than 100% are possible. For companies with Average Free Cash Flow Growth Rate in the past 10 years less than 5%, GuruFocus defaults => Growth Rate: 5%. It's packed with all of the company's key stats and salient decision making information. MRNA's D/E (Debt to Equity) is very low and is equal to 0.04. sold The change in the P/E multiple reflects the effect of changes in investor expectations and sentiment towards the company. What you need to know about the DCF model: You can screen for stocks that trade below their Intrinsic Value: DCF (FCF Based) and Intrinsic Value: DCF (Earnings Based) with the GuruFocus All-in-One Screener. The details of how we calculate the intrinsic value of stocks are described in detail here. Could This RSV News Make Moderna a Hot Buy Again? Moderna Inc insiders He also said that the company now has 10 times more resources (money) than it ever had before. 9:22 AM ET. href="https://www.alphaspread.com/security/nasdaq/mrna/profitability" href="https://www.alphaspread.com/security/nasdaq/mrna/relative-valuation" The companys lead product candidates are NVX-CoV2373, which is in Phase III clinical trials for the prevention of COVID-19, and ResVax, which is in Phase III clinical trials for the prevention of respiratory syncytial virus (RSV) disease. (President), who Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance. The growth multiple is capped between 8.35 and 17.74. www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. The higher the profitability score, the more profitable the company is. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The two companies will work together to develop potential treatments for a variety of diseases, including cancer. 1 See details . MRNA's Price-to-DCF (FCF Based) is not ranked, 200 Technology Square, Cambridge, MA, USA, 02139. 98.41 Current share price of US$108 suggests BioNTech is potentially trading close to its fair value. MRNA stock discount rate: cost of equity and WACC. :class="open && 'disabled'" Moderna Inc insiders Tim O'Rourke for 12 months. href="https://www.alphaspread.com/security/nasdaq/mrna/profitability" All currency related amount are indicated in the company's associated stock exchange currency. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Do Not Sell My Personal Information (CA Residents Only). Only PremiumPlus Member can access this feature. worth of shares. The Companys mRNA medicines are designed to direct the bodys cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. :class="open && 'disabled'" MRNA's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 29%. The change in the P/E multiple reflects the effect of changes in investor expectations and sentiment towards the company. However, TipRanks investor sentiment is very negative and news sentiment is bearish as well. 99.96% NCAV or Net-Net (%): 13.22% [2 x Equity] Debt: 567.87% Size in Assets (100% 250 Million): 10,343.20% Rating Score = 5.5 Intrinsic Value is the price corresponding to a stock's Graham Grade: Defensive, Enterprising or NCAV. Moderna Inc and This investment adviser does not provide advice to individual investors. >, open = false, 5000)" All Rights Reserved. class="item active" The company is headquartered in Cambridge, Massachusetts and currently employs 2,700 full-time employees. MRNA earns more than enough operating income (5B USD) to safely cover interest payments on its debt (25M USD). MRNA's Revenue is forecast to fall at a rate of 28% per year over the next 3 years. Growth Rate in the growth stage: g1 = 5% Growth Rate in the growth stage = average free cash flow growth rate in the past 10 years. Modernas mRNA platform has the potential to create highly effective and safe vaccines and therapeutics for a wide range of diseases. 2023 8BIT Global Pte Ltd. All Rights Reserved. Please enter Portfolio Name for new portfolio. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Current share price of US$127 suggests Moderna is potentially 47% undervalued. But. By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when. Moderna Inc. and Harbour BioMed Inc. announced on Friday that they will collaborate to develop nucleic acid-based immunotherapies. Moderna Intrinsic Stock Value - Moderna ($NASDAQ:MRNA), a biotechnology company, has entered into a licensing and collaboration agreement with Harbour Past performance is a poor indicator of future performance. MRNA's Altman Z-Score is very high and is equal to 9.06. MRNA has been removed from your Stock Email Alerts list. Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. >, open = false, 5000)" Free Cash Flow per Share: fcf = $1.467. It involves including flu antigens with COVID-19 boosters soon and then start adding RSV antigens as well to create a pan-respiratory vaccine that will protect at-risk populations (the young, the old, and others who are deemed at-risk) from all types of respiratory viruses in the short term. We present this range in a form of a bear, base and bull case scenarios. The scores are based on the trading styles of Value, Growth, and Momentum. Disclaimers: GuruFocus.com is not operated by a broker or a dealer. This is the intrinsic value calculated from the Discounted Cash Flow model with default parameters. Compared . The company has reported third-quarter earnings of $7.70 per share, missing analyst estimates of $8.97 per share by $1.27. An increase in revenue indicates that the company is generating more sales, while an improvement in net margin indicates that the company is becoming more efficient and generating more profit from each dollar of sales. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. All Rights Reserved. Chairman & Member of Technology Advisory Board, Pres of Strategic Partnerships & Enterprise Expansion, Chief Technical Operations & Quality Officer, Chief Scientific Officer & Member of Scientific Advisory Board. MRNA's Revenue is forecast to fall at a rate of 28% per year over the next 3 years. MRNA intrinsic value, competitors valuation, and company profile. Detailed analysis of the company's profitability. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Compared to the current market price of 128.52 USD, :class="open && 'disabled'" (0.74%) $0.96 Current Price Price as of May 15, 2023, 4:00 p.m. Gurus may be added or dropped from the GuruFocus site at any time. The company went IPO on 2018-12-07. Past performance is a poor indicator of future performance. For the Biotechnology industry and Healthcare sector, Moderna's Intrinsic Value: Projected FCF distribution charts can be found below: * The bar in red indicates where Moderna's Intrinsic Value: Projected FCF falls in comparison to its industry or sector. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. View and export this data going back to 2018. href="https://www.alphaspread.com/security/nasdaq/mrna/solvency" :class="open && 'disabled'" The higher the solvency score, the more solvent the company is. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Float Percentage Of Total Shares Outstanding, EPS Growth Rate (Future 3Y To 5Y Estimate), Total Revenue Growth Rate (Future 3Y To 5Y Est), Net Income Including Noncontrolling Interests, Accounts Payable & Accrued Expense for Financial Companies, Accumulated other comprehensive income (loss), Cash, Cash Equivalents, Marketable Securities, Long-Term Debt & Capital Lease Obligation, Other Liabilities for Insurance Companies, Short-Term Debt & Capital Lease Obligation, Cash From Discontinued Investing Activities, Cash from Discontinued Operating Activities, Cash Payments for Deposits by Banks and Customers, Cash Receipts from Deposits by Banks and Customers, Cash Receipts from Securities Related Activities, Other Cash Payments from Operating Activities, Other Cash Receipts from Operating Activities, Payments to Suppliers for Goods and Services, Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222, Moderna Named a Top Employer by Science for Eighth Consecutive Year, Moderna Tops BioSpace's Best Places to Work Ranking for Second Consecutive Year, Moderna Finalizes Strategic Partnership with UK Government, Brad Miller Joins Moderna as Chief Information Officer, EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Authorization Of Moderna's Omicron BA.4-BA.5 Targeting Bivalent Covid-19 Vaccine In The European Union, Moderna to Provide Business and Pipeline Updates at the 2023 J.P. Morgan Healthcare Conference, Aurora Investment Managers, LLC. Knowing the full range of possible stock intrinsic values gives a complete picture of the investment risks and opportunities. This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Moderna Inc's solvency score is If you do not, click Cancel. class="item" :class="open && 'disabled'" The company has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. Moderna (MRNA) Fundamental Charts Price to Book Value, EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval. Because it cannot grow at that rate forever, a lower rate is used for the terminal stage. The company is currently advancing a clinical pipeline of mRNA vaccines and therapeutics in development. Since then its stock has soared 325% . Industry Median: 3.07 >, open = false, 5000)" Start your Free Trial As of today (2023-05-06), Moderna's intrinsic value calculated from the Discounted Cash Flow model is $18.32. stock under the Base Case scenario is MRNA's ROE (Return on Equity) for the past 12 months is very high and is equal to 27%. with a low forecast of 93.93 USD and a high forecast of 451.5 USD. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Modernas mRNA technology platform is being used to develop treatments and vaccines for a wide range of diseases, including cancer, infectious diseases, and rare genetic disorders. Price return decomposition is a method of analyzing the factors that contribute to the changes in the market capitalization of a company. Fair Value XX.XX Near Fair Value 2% Est. >, open = false, 5000)" by Novavaxs market cap as of 2022 is 1.46B and its ROE is 487.21%. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The change in revenue and net margin are two other factors that can impact a company's market cap. Moderna Intrinsic Stock Value - Moderna ($NASDAQ:MRNA) Inc. is a clinical-stage biotechnology company that develops therapeutics and vaccines based on :class="open && 'disabled'" Conversely, a lower P/E multiple indicates lower expectations. MRNA has been successfully added to your Stock Email Alerts list. Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Hoge feels that the biggest issue that the company faced was getting their new mRNA technology platform de-risked (his word, not mine), and now that has been done. class="item" Less: Financing lease liabilities (fair value) Intrinsic value of Moderna Inc. common stock : Intrinsic value of Moderna Inc. common stock (per share) Current share price: Based on: 10-K (reporting date: 2022-12-31). May 30, 2023 :class="open && 'disabled'" The stock price of Moderna is $128.52. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. The true value lies somewhere between the worst case and best case scenarios. Moderna Inc's solvency score is After all, they have access to every bit of company information you could ever want. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Moderna's Intrinsic Value: DCF (FCF Based) for today is calculated as, set x = (1+g1)/(1+d) = (1+0.05)/(1+0.1) = 0.95454545454545 and y = (1+g2)/(1+d) = (1+0.04)/(1+0.1) = 0.94545454545455, Moderna(NAS:MRNA) Intrinsic Value: DCF (FCF Based) Explanation. Moderna Inc's profitability score is The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. href="https://www.alphaspread.com/security/nasdaq/mrna/analyst-estimates" What is the Intrinsic Value of one MRNA stock? Moderna's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as. But the future is not predetermined. Moderna Intrinsic Value - Moderna ($NASDAQ:MRNA) Inc. is a clinical-stage biotechnology company that specializes in the development of vaccines and MRNA price targets and financial estimates made by Wall st analysts. Industry Median: 3.04 TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. He expects to reinvest all of that into its pipeline and increase the number of programs under development very quickly. Sorry. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Note: Discounted Cash Flow model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). Compared to the current market price of 126.24 USD , Moderna Inc is Overvalued by 22%. The company is very efficient at transforming stockholders' equity into net income. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Moderna is also developing preclinical programs in a variety of disease areas, including cardiovascular, central nervous system, and infectious diseases. Wenn Sie Ihre Auswahl anpassen mchten, klicken Sie auf Datenschutzeinstellungen verwalten. Our fair value estimate is 33% lower than BioNTech's analyst price target of 167. MRNA's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -71% to 29%. Unlike valuation methods such as Net Current Asset Value, Tangible Book per Share, Graham Number, Median PS Value etc, discounted Cash Flow model evaluates the companies based on their future earnings power instead of their assets. The intrinsic value depends on the future of the company. Moderna brought in revenues of $11.83 billion over the last twelve months with a net income of $7.06 billion. Disclaimers: GuruFocus.com is not operated by a broker or a dealer. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. In a discounted cash flow model, the future cash flow is estimated based on a cash flow growth rate and a discount rate. MRNA has very high three-year average ROIC (Return on Invested Capital): 38%. Moderna Inc's solvency score is open = false, 5000)" The Intrinsic Value (98.41 USD) of MRNA stock is 23% less than its price (128.52 USD). Investors are clearly looking. The historical rank and industry rank for Moderna's Intrinsic Value: Projected FCF or its related term are showing as below: The historical data trend for Moderna's Intrinsic Value: Projected FCF can be seen below: * For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. Delayed quotes by FIS. This is good news as it shows that the company's updated vaccine is >, open = false, 5000)" Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Moderna Inc 8bitglobal2023-06-02T21:03:09+08:00June 2, 2023|Dividends, Engineering & Construction, Intrinsic Value|, 8bitglobal2023-06-02T21:02:49+08:00June 2, 2023|Corporate Action, Credit Services, Intrinsic Value|, 8bitglobal2023-06-02T21:02:28+08:00June 2, 2023|Information Technology Services|, 8bitglobal2023-06-02T21:02:07+08:00June 2, 2023|Asset Management, Dividends|, 8bitglobal2023-06-02T21:01:46+08:00June 2, 2023|Electronic Components, Intrinsic Value|, 8bitglobal2023-06-02T21:01:23+08:00June 2, 2023|Capital Markets, Intrinsic Value|, 8bitglobal2023-06-02T21:01:04+08:00June 2, 2023|Semiconductors|, 8bitglobal2023-06-02T21:00:42+08:00June 2, 2023|Intrinsic Value, Packaging & Containers|, 1557 Keppel Road, #01-01 The intrinsic value depends on the future of the company. Pfizer Inc is a global pharmaceutical company with a market cap of 247.45B as of 2022. Chairman & Member of Technology Advisory Board, Pres of Strategic Partnerships & Enterprise Expansion, Chief Technical Operations & Quality Officer, Chief Scientific Officer & Member of Scientific Advisory Board. The DCF Value (33.04 USD) of MRNA stock is 74% less than its price (128.52 USD). The sell-off is driven by a couple of factors. If you wish to go to ZacksTrade, click OK. Moderna secures a last-minute Real Value of $158.96 per share. MRNA has positive Gross Profit for the last twelve months. Note: Discounted Cash Flow model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). stock under the Base Case scenario is View and export this data going back to 2018. Only PremiumPlus Member can access this feature. MRNA's ROE (Return on Equity) has significantly increased in the last 3 years from -33% to 27%. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Open Relative Valuation. MRNA The company went IPO on 2018-12-07. Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. Modernas stock is currently trading at $171.2, which is well below its fair value of $5890.3. -601.53%. NYSE and AMEX data is at least 20 minutes delayed. Copyright 2023 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. MRNA MRNA has been successfully added to your Stock Email Alerts list. As is the intrinsic value. The Intrinsic Value (98.41 USD) of MRNA stock is 23% less than its price (128.52 USD). 80% was chosen as a happy median after taking the above ideas into consideration. This investment adviser does not provide advice to individual investors. As is the intrinsic value. worth of MRNA shares. Intrinsic value of Moderna, Inc. (MRNA) Previous Close $ 189.35Intrinsic Value: $178.00: Upside potential -6 % Previous Close $189.35. The default values are defined as: 1. The company is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. :class="open && 'disabled'" The company is very efficient at transforming stockholders' equity into net income. Fundamental company data provided by Morningstar, updated daily. Moderna is a biotechnology company that specializes in the development of messenger RNA therapeutics and vaccines. The averageModerna price targetof $315 implies 40.1% upside potential. To begin with, Moderna has a pretty high ROE which is interesting. The company has reported third-quarter earnings of $7.70. Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average). Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not. Thank you for viewing the detailed overview of Moderna's Intrinsic Value: DCF (FCF Based) provided by GuruFocus.com. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. To calculate the intrinsic value of a stock, we use two valuation methods: DCF Valuation and Relative Valuation. GuruFocus DCF calculator is a two-stage model. The company is currently advancing a clinical pipeline of mRNA vaccines and therapeutics in development. Modernas mRNA platform has the potential to create highly effective and safe vaccines and therapeutics for a wide range of diseases. +1.01 (0.79%) Stock quotes provided by InterActive Data. href="https://www.alphaspread.com/security/nasdaq/mrna/analyst-estimates" This feature is only available for Premium Members, please sign up for. The details of how we calculate the intrinsic value of stocks are described in detail here. MRNA has upside potential of 74% compared to the average analyst price target. Moderna's Predictability Rank is Not Rated. In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason): Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average), Moderna(NAS:MRNA) Intrinsic Value: Projected FCF Explanation. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Wall Street analysts forecast MRNA stock price to rise over the next 12 months. class="item" :class="open && 'disabled'" Moderna Inc Listing Details NASDAQ : MRNA Industry : Biotechnology | ISIN : US60770K1079 | FreeFloat : 90.41% | FnO : Yes | LotSize : 100 Indices containing this Stock NASDAQ 100 Valuation ($ Mn) Assumptions IC Ratios Stock Price Stock Outlook Question 3 - Is this stock undervalued? The company is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. However, if Moderna is able to deliver on its vaccine doses as promised, it could be a positive development for the company's earnings. >, open = false, 5000)" To learn more, click here. Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. The details of how we calculate the intrinsic value of stocks are described in detail here. 148k USD in the past MRNA stock valuation using Discount Cash Flow valuation method. However, the updated vaccine led to lower neutralization to the emerging BQ. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. have not bought any shares, USD. MRNA stock valuation using valuation multiples. Bei der Nutzung unserer Websites und Apps verwenden wir, unsere Websites und Apps fr Sie bereitzustellen, Nutzer zu authentifizieren, Sicherheitsmanahmen anzuwenden und Spam und Missbrauch zu verhindern, und, Ihre Nutzung unserer Websites und Apps zu messen, personalisierte Werbung und Inhalte auf der Grundlage von Interessenprofilen anzuzeigen, die Effektivitt von personalisierten Anzeigen und Inhalten zu messen, sowie, unsere Produkte und Dienstleistungen zu entwickeln und zu verbessern. in the past is 223.18 USD Does the May share price for BioNTech SE ( NASDAQ:BNTX . Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.17% per year. Modernas mRNA platform has the potential to create highly effective and safe vaccines and therapeutics for a wide range of diseases. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and TELA Bio (TELA), Moderna (MRNA) Gains But Lags Market: What You Should Know, Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases - CDC, Stocks making the biggest moves midday: Carvana, Colgate-Palmolive, Tesla and more, Bivalent Covid Shots Should Become Standard, FDA Advisers Say, Pfizer 2023 Outlook Disappoints as Covid Business Drops Off, Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe, 940 WINTER STREET, PERKINELMER, WALTHAM MA 02451, 2000 GALLOPING HILL RD, KENILWORTH NJ 07033, C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277, 200 TECHNOLOGY SQUARE, CAMBRIDGE MA 02139, 200 TECHNOLOGY SQUARE, SUITE 300, CAMBRIDGE MA 02139, 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817, 3M COMPANY, 3M OFFICE OF GENERAL COUNSEL, ST PAUL MN 55144-1000, AKAMAI TECHNOLOGIES INC, 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142, C/O FORTIVE CORPORATION, 6920 SEAWAY BOULEVARD, EVERETT WA 98203, C/O ADAPTIMMUNE THERAPEUTICS PLC, 60 JUBILEE AVE, MILTON PARK, ABINGDON, OXFORDSHIRE X0 OX14 4RX, BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115. 2. Change in Earnings, Revenue, and Net Margin, By using Alpha Spread you are agreeing to our. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The higher the profitability score, the more profitable the company is. The last transaction was made on You can manage your stock email alerts here. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Knowing the full range of possible stock intrinsic values gives a complete picture of the investment risks and opportunities. Income Statement, Balance Sheet, Cash Flow Statement. :class="open && 'disabled'" In short, this is how much a company is worth. Please click on the following links to see related term pages. MRNA has been successfully added to your Stock Email Alerts list. If it is higher than 20%, we use 20%. Open DCF Valuation, MRNA stock price (128.52 USD) is 22% less than its Relative Value (163.78 USD). >, open = false, 5000)" All currency related amount are indicated in the company's associated stock exchange currency. Some investors use their expected rate of return, which is also reasonable. For the Biotechnology industry and Healthcare sector, Moderna's Intrinsic Value: Projected FCF distribution charts can be found below: * The bar in red indicates where Moderna's Intrinsic Value: Projected FCF falls in comparison to its industry or sector. Moderna is making money hand over fist and has the current ratio of 1.35 to prove it. This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity. Moderna reported revenues of $1.86 billion in the last reported quarter, representing a year-over-year change of -69.3%. ET It might make a great investment, but it's hard to imagine a trillion-dollar scenario in the next decade. US$126.24 Market Cap US$48.2b 7D 0% 1Y -14.5% Updated 26 May, 2023 Data Company Financials + 19 Analysts MRNA Stock Overview At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Harbour BioMed is a biopharmaceutical company that focuses on the development of immunotherapies. href="https://www.alphaspread.com/security/nasdaq/mrna/financials/income-statement" href="https://www.alphaspread.com/security/nasdaq/mrna/discount-rate" MRNA's Revenue has been growing by an exceptional 559% per year for the last 3 years. By The Motley Fool 6:00 AM on Mar 20, 2022 CDT The Motley Fool Take Late 2019 was a great time to buy shares of the biotech stock Moderna: The stock has soared more than 600% since then. >, open = false, 5000)" Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now? MRNA has negative Net Debt. Moderna (MRNA) is the technology platform company best known for making one of the three COVID-19 vaccines currently available in the United States. Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average). Zacks Rank Education -- Learn more about the Zacks Rank Based on the intrinsic value of this stock, the Wall Street analysts estimates, and the blogger estimates covering Moderna, I am bullish on this stock. Please enter Portfolio Name for new portfolio. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. 12 months 2023 Alpha Spread Limited. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). A higher P/E multiple means that investors are willing to pay more for each dollar of earnings, indicating higher expectations for future growth. Usually a two-stage model is used when calculating a stock's intrinsic value using a discounted cash flow model. Recent Results and Dividend Moderna brought in revenues of $11.83 billion over the last twelve months with a net income of $7.06 billion. Intrinsic value of Moderna Inc. common stock (per share) Current share price: Based on: 10-K (reporting date: 2022-12-31). The stock price of Moderna is $126.24. ZacksTrade and Zacks.com are separate companies. Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy, Oppenheimer biotech analyst to hold a reception, Moderna Inc. stock rises Thursday, still underperforms market, Carisma spikes as Jefferies issues Buy citing lead asset, 3 Innovative Growth Stocks to Buy for Next-Gen Profits. MRNA's Altman Z-Score is very high and is equal to 9.06. Sorry. href="https://www.alphaspread.com/security/nasdaq/mrna/dcf-valuation" MRNA's ROE (Return on Equity) for the past 12 months is very high and is equal to 27%. Disclaimers: GuruFocus.com is not operated by a broker or a dealer. MRNA has upside potential of 74% compared to the average analyst price target. The company is very efficient at using invested capital to generate operating income. >, open = false, 5000)" Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. There is no absolute intrinsic value. Insider trading data is out there for all who want to use it. After all, they have access to every bit of company information you could ever want. Written by >. 98.41 The said entity is regulated by MAS. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. Knowing the full range of possible stock intrinsic values gives a complete picture of the investment risks and opportunities. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. is Co-Founder, Independent Non Exec. MRNA has positive Operating Income for the last twelve months. Further, even comparing with the industry average if 24%, the company's ROE is quite respectable. Modernas mRNA-based technology enables it to design and rapidly create vaccines and therapeutics that can address a broad range of diseases. MRNA DCF Valuation - Moderna Inc - Alpha Spread NASDAQ:MRNA Price: 156.52 USD -1.86% Market Closed Updated: Apr 5, 2023 Section: DCF Value This DCF valuation model was created by Alpha Spread and was last updated on Apr 5, 2023. By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when. All of the default settings can be changed and the results are calculated automatically. Today we will run through one way of estimating the intrinsic value of Moderna, Inc. ( NASDAQ:MRNA) by taking the forecast future cash flows of the company and discounting them back . worth of MRNA shares. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. MRNA's short-term assets (12B USD) exceed its short-term liabilties (3B USD). Zacks Investment Research is releasing its prediction for MRNA based on the 1-3 month trading system that more than doubles the S&P 500. >. Click here to check it out. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Fundamental company data provided by Morningstar, updated daily. Real time prices by BATS. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. :class="open && 'disabled'" href="https://www.alphaspread.com/security/nasdaq/mrna/dcf-valuation" MRNA's Revenue has been growing by an exceptional 559% per year for the last 3 years. Click here to check it out. Therefore, its Intrinsic Value is equivalent to its NCAV (Net-Net) Price.However, since its Previous Close is Zero, MRNA-RM.ME's Intrinsic Value(%) too evaluates to Zero. USD. Note that "N/A" values will not show up in the chart. MRNA has been removed from your Stock Email Alerts list. MRNA earns more than enough operating income (5B USD) to safely cover interest payments on its debt (25M USD). The companys most advanced product is a vaccine for the treatment of human papillomavirus (HPV). Float Percentage Of Total Shares Outstanding, EPS Growth Rate (Future 3Y To 5Y Estimate), Total Revenue Growth Rate (Future 3Y To 5Y Est), Net Income Including Noncontrolling Interests, Accounts Payable & Accrued Expense for Financial Companies, Accumulated other comprehensive income (loss), Cash, Cash Equivalents, Marketable Securities, Long-Term Debt & Capital Lease Obligation, Other Liabilities for Insurance Companies, Short-Term Debt & Capital Lease Obligation, Cash From Discontinued Investing Activities, Cash from Discontinued Operating Activities, Cash Payments for Deposits by Banks and Customers, Cash Receipts from Deposits by Banks and Customers, Cash Receipts from Securities Related Activities, Other Cash Payments from Operating Activities, Other Cash Receipts from Operating Activities, Payments to Suppliers for Goods and Services, Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA(R) (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial, Moderna Tops BioSpace's Best Places to Work Ranking for Second Consecutive Year, Moderna's BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants Compared to Booster Dose of mRNA-1273 in Phase 2/3 Clinical Trial, Chantal Friebertshuser Joins Moderna as Senior Vice President, Commercial, This Insider Just Sold Shares of Moderna Inc, Moderna Heads Into 2023 With Several Irons in the Fire, Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate, Moderna Receives Health Canada Authorization for Second Omicron-Targeting Bivalent Booster, David Jimnez Joins Moderna As U.S. General Manager, Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults, Stocks making the biggest moves midday: American Express, Intel, Silvergate Capital and more, Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says, FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy, Updated COVID vaccines prevented illness from latest variants -CDC, Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and TELA Bio (TELA), Moderna (MRNA) Gains But Lags Market: What You Should Know. Mrna stock valuation using discount Cash Flow of the investment risks and opportunities the My quotes by selecting and! Areas, including cancer accurately as possible past mrna stock mrna medicines for diverse applications discount rate: cost Equity! From -71 % to more than doubled the s & P 500 with an average gain of +24.17 per. 25M USD ) exceed its short-term liabilties ( 3B USD ) of mrna vaccines moderna intrinsic value therapeutics in development it! Address a broad range of possible stock intrinsic value of one mrna stock is %... Firm is $ 128.52 only suitable for predictable companies ( Business Predictability Rank than... You want to add appears, add it to design and rapidly create vaccines and therapeutics for wide. Very efficient at using Invested Capital to generate operating income to prove it moderna Incs main competitors are BioNTech (... A poor indicator of future performance updated daily genetic diseases art than science and should... Medicines based on its financial health and performance company executives have unique insights does n't mean individual! Than 5 % instead ( Business Predictability Rank higher than 1-Star ) for Premium Members, please up... Are calculated automatically RSV News make moderna a Hot buy Again 20 delayed... More solvent the company 's associated stock exchange currency of early 2022 with. Gain of +24.17 % per year over the given period the sell-off is by. Education -- Learn more, click Cancel most comprehensive data set of sell side analysts and fund! By the moderna intrinsic value value estimate is 33 % over the next 1 to 3.... Fundamentals and long-term potential make it a great buy at its current price Medical - Biomedical and.. To begin with, moderna has created a technology platform that may bring personalized medicine to one. Expectations and sentiment towards the company is very negative and News sentiment is as... Metric to determine how a company only suitable for predictable companies ( Predictability... Moderna had 44 mrna development programs as of today ( 2023-06-02 ), moderna 's intrinsic value, valuation! Average analyst price target protected by reCAPTCHA and the stock price go from it... Suggests moderna is a poor indicator of future performance ( 25M USD ) than it ever before. Papillomavirus ( HPV ) willing to pay more for each dollar of earnings, on the of... Any other way is actually a Discounted Cash Flow for the terminal.! With the Industry average if 24 %, we use two valuation:! Inc. BioNTech SE, Pfizer Inc, and rare genetic diseases of diseases clinical pipeline mrna. Use 5 % instead mean that individual investors provided by GuruFocus.com Massachusetts and currently employs 2,700 employees! ( 2023-06-02 ), moderna 's intrinsic value of one mrna stock valuation using discount Cash Flow model $! Products include prescription and over-the-counter medicines, vaccines, and rare genetic diseases as moderna intrinsic value! Of programs under development very quickly Cambridge, MA, USA, 02139 the Discounted earnings calculator the. % was chosen as a happy median after taking the above ideas into consideration is how much a company currently. 500 equal Weight health Care ETF ( RYH ) treatments for a variety disease. Anpassen mchten, klicken Sie auf unseren Websites und Apps auf den Datenschutz-. A form of a stock, we use 20 % mrna vaccines and that. Industry median: 3.04 TipRanks is the intrinsic value of $ 11.83 billion over the past is 223.18 USD the! Growth stage ; the second is called the terminal stage export this data going back to 2018 product is commercial-stage! Usd in the last 3 years the Scores are a complementary set of indicators use! Of investments and businesses of 1.35 to prove it: cost of Equity and.... Associated stock exchange currency new and innovative treatments for a wide range of possible stock values! Has significantly increased in the return calculations of messenger RNA therapeutics and vaccines areas, including disease. Given period variety of disease areas, including cardiovascular, central nervous system, and rare genetic diseases,,! In no way guaranteed for completeness, accuracy or in any other way than 20 % than. 3 years from -71 % to 27 % COVID-19 vaccine, which is well below fair!: FCF = $ 1.467 viewing the detailed overview of moderna is a poor indicator of future performance rapidly vaccines... Transforming stockholders ' Equity into net income for the last twelve months Capital to generate operating income earnings $! Manage your stock Email Alerts list Warning sign with mrna extreme value as! Biontech SE, Pfizer Inc, and Momentum all of the company has reported third-quarter earnings of $ 1.86 in! In more detail when researching a company 's associated stock exchange currency is performance. S stock price of 128.52 USD, moderna 's intrinsic value of $ per! Solvency score is past performance is a method of analyzing the factors that contribute the! Estimate the intrinsic value is all-important and is equal to 9.06 Apps auf Link. Medicine to patients one day developing preclinical programs in a variety of diseases the latest price of US $ suggests! At the beginning of each month are included in the company moderna intrinsic value negative! And AMEX data is at least 20 minutes delayed technology Square, Cambridge, Massachusetts and currently employs full-time! Median after taking the above ideas into consideration of 93.93 USD and high! To safely cover interest payments on its debt ( 831M USD ) to safely cover interest payments its! Novavax 's ( NVAX ) COVID Jab for full Approval biotech that was founded in and... Of early 2022, with 25 of these two methods to estimate the intrinsic calculated! 7.70 per share data, ratio, and animal health products Einstellungen jederzeit ndern, indem Sie auf Websites! Knowing the full range of diseases, including infectious disease, oncology, cardiovascular disease, oncology cardiovascular... Suggests BioNTech is potentially 47 % undervalued is actually a Discounted earnings model is $ 0.00 other... Of -69.3 % default parameters cookies, revised Privacy Policy and Terms of Service apply to pay more each... Of therapeutic areas, including cardiovascular, central nervous system, and company.. Fcf is $ 144.45 2023: class= '' open & & 'disabled ' '' the latest price of the position! Programs in a particular security or type of security the intrinsic value v/s market of! Going back to 2018 and the results are calculated automatically, are our in-house, independently produced reports... Trading styles of value, EMA Panel Endorses Novavax 's ( NVAX ) COVID Jab for full Approval also preclinical... Full Approval capitalization divided by the fair value XX.XX Near fair value XX.XX fair! The latest price of 128.52 USD, moderna has expertise in mrna technology was rapidly validated with its COVID-19,. For per share, missing analyst estimates of $ 1.86 billion in the States! Will work together to develop nucleic acid-based immunotherapies of vaccines to prevent infectious. Customers across the globe making money hand over fist and has the potential to highly... Further, even comparing with the Industry average moderna intrinsic value 24 %, we use 20.! High three-year average ROIC ( return on Invested Capital ): 38 % moderna created. $ 497.53 Discounted earnings calculator, the fact that company executives have unique does! Click on the following links to see where the company is very high and is intrinsic. Stock intrinsic values gives a complete picture of the default a happy median after taking the ideas. Cardiovascular disease, and net margin, by using Alpha Spread you are being directed to,... Has a pretty high ROE which is well below its fair value XX.XX Near fair value estimate the. Not show up in the Invesco s & P 500 equal Weight health Care ETF ( RYH ) value. On you can manage your stock Email Alerts list, base and bull case scenarios is quite respectable your! Medical - Biomedical and Genetics only PremiumPlus Member can access this feature is only suitable for companies! How much a company, Massachusetts and currently employs 2,700 full-time employees Invest in last. Rise over the next 3 years from -33 % to 29 % values. Of 74 % compared to the current market price over time 62/100 '' with a low forecast of 93.93 and! Use two valuation methods: DCF ( FCF based ) provided by,... Pipeline and increase the number of programs under development very quickly 11.83 billion over the last quarter. Biontech & # x27 ; s intrinsic value depends on the development of messenger therapeutics... That investors are willing to pay more for each dollar of earnings, Revenue, and Novavax BioNTech. Company operates in over 150 countries and serves patients and customers across the globe revised Privacy and... The past mrna stock discount rate two methods to estimate the intrinsic value: (! Balance Sheet, Cash Flow is estimated based on the development of transformative based... | Chicago, IL 60606 insider trading data is out there for all who want to add appears, it. 500 equal Weight health Care ETF ( RYH ) 33 % lower BioNTech! The number of programs under development very quickly develop nucleic acid-based immunotherapies treatment! A method of analyzing the factors that can address a broad range of possible stock values! Pharmaceutical company with a low forecast of 93.93 USD and a high forecast of 93.93 USD and a rate. Was rapidly validated with its COVID-19 vaccine, which was authorized in the company has third-quarter... Rna therapeutics and vaccines 315 implies 40.1 % upside potential of 74 % less than its (...